AI Article Synopsis

  • Pulmonary surfactant is a crucial lipid/protein mixture that lowers surface tension in the lungs, primarily involving the proteins SP-B and SP-C, which are essential for its proper function.
  • Despite prior theories suggesting interactions between SP-B and SP-C, this study provides the first direct evidence through extensive fluorescence spectroscopy analysis, revealing complex behaviors and interactions depending on their concentrations.
  • Findings indicate that SP-C may induce conformational changes in SP-B, suggesting a synergistic relationship that enhances pulmonary surfactant functionality.

Article Abstract

Pulmonary surfactant is a lipid/protein mixture that reduces surface tension at the respiratory air-water interface in lungs. Among its nonlipidic components are pulmonary surfactant-associated proteins B and C (SP-B and SP-C, respectively). These highly hydrophobic proteins are required for normal pulmonary surfactant function, and whereas past literature works have suggested possible SP-B/SP-C interactions and a reciprocal modulation effect, no direct evidence has been yet identified. In this work, we report an extensive fluorescence spectroscopy study of both intramolecular and intermolecular SP-B and SP-C interactions, using a combination of quenching and FRET steady-state and time-resolved methodologies. These proteins are compartmentalized in full surfactant membranes but not in pure 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) vesicles, in accordance with their previously described preference for liquid disordered phases. From the observed static self-quenching and homo-FRET of BODIPY-FL labeled SP-B, we conclude that this protein forms homoaggregates at low concentration (lipid:protein ratio, 1:1000). Increases in polarization of BODIPY-FL SP-B and steady-state intensity of WT SP-B were observed upon incorporation of under-stoichiometric amounts of WT SP-C. Conversely, Marina Blue-labeled SP-C is quenched by over-stoichiometric amounts of WT SP-B, whereas under-stoichiometric concentrations of the latter actually increase SP-C emission. Time-resolved hetero-FRET from Marina Blue SP-C to BODIPY-FL SP-B confirm distinct protein aggregation behaviors with varying SP-B concentration. Based on these multiple observations, we propose a model for SP-B/SP-C interactions, where SP-C might induce conformational changes on SP-B complexes, affecting its aggregation state. The conclusions inferred from the present work shed light on the synergic functionality of both proteins in the pulmonary surfactant system.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005437PMC
http://dx.doi.org/10.1074/jbc.RA117.000222DOI Listing

Publication Analysis

Top Keywords

pulmonary surfactant
16
sp-b sp-c
12
sp-b
10
proteins sp-b
8
sp-c
8
sp-b/sp-c interactions
8
bodipy-fl sp-b
8
surfactant
6
pulmonary
5
proteins
5

Similar Publications

Fluoride Induces Toxic Effects on the A549 Pulmonary Cell Line at Non-cytotoxic Concentrations.

Biol Trace Elem Res

January 2025

Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, AvInstituto Politécnico Nacional 2508, Col San Pedro ZacatencoCDMX, C.P. 07360, Mexico City, Mexico.

Fluoride is emitted into the air not only through gas emissions but also from volcanic ash, leading to contact via inhalation. Therefore, the objective of the present study was to evaluate the cellular and biochemical responses in the A549 cell line after exposure to NaF (sodium fluoride) concentrations lower than those previously used in other studies to determine the impact on the lung epithelium. A549 cells were exposed to different concentrations (0.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to identify serum surfactant protein D (SP-D) levels that can aid in the diagnosis and prognosis of COVID-19, while also developing a new prognostic scale called the CHARISMA Score.
  • Researchers conducted assessments on 64 COVID-19 patients and 16 healthy individuals, comparing various subgroups based on factors such as PCR results and severity of illness, ultimately finding significant differences in serum SP-D levels.
  • Results indicated that higher SP-D levels and CHARISMA scores correlated with greater disease severity and mortality risk, establishing the potential of these measures for predicting patient outcomes in COVID-19 pneumonia.
View Article and Find Full Text PDF

Revisiting surfactant protein D: an immune surveillance molecule bridging innate and adaptive immunity.

Front Immunol

January 2025

Department Integrative Agriculture, College of Agriculture and Veterinary Medicine, United Arab Emirates University, Al Ain, United Arab Emirates.

Surfactant protein D (SP-D) is a C-type lectin that was originally discovered as a lung surfactant associated phospholipid recognising protein. It was originally shown to be of great importance in surfactant turnover and homeostasis in conjunction with another hydrophilic surfactant protein i.e.

View Article and Find Full Text PDF

Introduction Respiratory distress syndrome (RDS) is a leading cause of morbidity and mortality among preterm infants, necessitating effective treatment strategies. This study compared the efficacy of Beractant (SURVANTA®) to Poractant alfa (CUROSURF®) in treating RDS in preterm infants admitted to Tawam Hospital in the UAE. Methodology This retrospective study included preterm infants from 23+0 to 36+6 weeks of gestation with a diagnosis of RDS and treatment by Beractant or Poractant alfa within 48 hours of life between January 2020 and March 2023.

View Article and Find Full Text PDF

Comparative efficacy and safety of pulmonary surfactant delivery strategies in neonatal RDS: a network meta-analysis.

BMC Pulm Med

December 2024

Department of Neonatology, Children's Hospital of Chongqing Medical University, Chongqing, 400,014, China.

Purpose: To compare five pulmonary surfactant (PS) administration strategies for neonates with respiratory distress syndrome (RDS), including intubation-surfactant-extubation (InSurE), thin catheter administration, laryngeal mask airway (LMA), surfactant nebulization (SN), and usual care, with a particular emphasis on the comparison of the LMA and SN with other strategies.

Methods: We conducted a systematic search of MEDLINE, EMBASE, PUBMED, and Cochrane CENTRAL databases up to November 2023. Two authors independently conducted data extraction, and assessed bias using the Cochrane Risk of Bias Tool.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!